Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep319 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

What is the impact of being overweight on the progressive genius of Crohn’s disease?

Akkari Imen , Ameni Hassine , Soumaya Mrabet , Elhem Ben Jazia

Background: Overweight is becoming increasingly more common among patients with inflammatory bowel disease and plays a role in the development and course of the disease especially in Crohn’s disease (CD). However, there is currently little data on his impact on the evolutionary genius of CD. The aim of this study was to assess the impact of overweight on the epidemiological, clinical, therapeutic and progressive characteristics of CD.Patients and Me...

ea0073aep278 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Response to direct antiviral agents in chronic hepatitis C in patients with metabolic syndrome

Soumaya Mrabet , raida harbi , Akkari Imen , Elhem Ben Jazia

IntroductionDirect antiviral agents (DAAs) are a real revolution in the treatment of chronic hepatitis c (CHC). It is a short-term treatment with few side effects. Insulin resistance in patients with metabolic syndrome, causes the onset of steatosis, contributes to the progression to cirrhosis and decreases the chances of a response to treatment. The aim of our study was to evaluate the response to DAAs in patients with metablic syndrome.<p class="ab...

ea0073aep328 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Non alcoholic steatohepatitis related cirrhosis and hepatocellulair carcinoma: A ten years rerospective study

Soumaya Mrabet , Raida Harbi , Akkari Imen , Elhem Ben Jazia

IntroductionCurrently, the incidence of metabolic steatopathies is clearly increasing. Unlike simple fatty liver disease, non-alcoholic steatohepatitis (NASH) can progress to cirrhosis and hepatocellular carcinoma (HCC). The aim of our study was to determine the factors associated with these complications in patients with NASH.MethodsThis is a retrospective study including all cirrhotic patients followed betw...

ea0073aep358 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Impact of diabetes on liver fibrosis in chronic hepatitis C

Soumaya Mrabet , Raida Harbi , Akkari Imen , Elhem Ben Jazia

IntroductionChronic hepatitis C (CHC) is associated with an increased incidence of insulin resistance and diabetes mellitus. Obesity and insulin resistance are associated with faster progression of fibrosis in these patients. The aim of our study was to assess the impact of diabetes on the severity of hepatic fibrosis in patients followed for CHC.MethodsThis is a retrospective study conducted between January ...

ea0049ep780 | Endocrine Disruptors | ECE2017

Association of autoimmune endocrinopathies and celiac disease

Soumaya Mrabet , Imen Akkari , Taieb Ach , Koussay Ach , Elhem Ben Jazia

Introduction: Celiac disease (CD) is an immune-mediated small intestinal disorder that occurs in genetically susceptible people. It is significantly associated with other autoimmune disorders represented mainly by type 1 diabetes and autoimmune dysthyroidism.Material and methods: We report 23 observations of patients with autoimmune endocrinopathies associated with celiac disease.Results: There are 23 patients with an average age o...

ea0049ep762 | Clinical case reports - Thyroid/Others | ECE2017

Multiple autoimmune syndrome: about six observations

Mrabet Soumaya , Hammami Aya , Nour Elleuch , Hanen Jaziri , Aida Ben Slama , Ahlem Braham , Salem Ajmi , Ksiaa Mehdi , Ali Jmaa , Elhem Ben Jazia

Introduction: Autoimmune disorders are known to be more frequent in women and often associated each others, but it is rare to see multiple autoimmune diseases in a single patient. Multiple autoimmune syndrome (MAS) is defined as the combination of at least three autoimmune diseases in the same patient. The pathogenesis of MAS is not known. Genetic, infectious, immunologic and psychological factors have all been implicated in its development.Observations:...